Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $574.96 billion, total revenue of $161.66 billion and a weighted average PE ratio of 46.52.
Market Cap
574.96B
Revenue
161.66B
Profits
12.36B
PE Ratio
46.52
Profit Margin
7.65%
Dividend Yield
0.32%
51 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 148.60B | -1.70% | 2,318,922 | 42.90B |
| 2 | DHR | Danaher Corporation | 132.07B | -1.57% | 2,814,654 | 23.82B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 40.34B | -0.65% | 443,453 | 3.93B |
| 4 | A | Agilent Technologies, Inc. | 30.94B | -1.05% | 1,690,994 | 6.53B |
| 5 | IQV | IQVIA Holdings Inc. | 23.70B | -0.75% | 2,248,698 | 15.50B |
| 6 | MTD | Mettler-Toledo International Inc. | 23.15B | -1.92% | 247,892 | 3.83B |
| 7 | NTRA | Natera, Inc. | 20.94B | 0.55% | 1,085,191 | 1.83B |
| 8 | WAT | Waters Corporation | 20.61B | -0.60% | 412,720 | 2.98B |
| 9 | LH | Labcorp Holdings Inc. | 20.30B | 0.26% | 503,834 | 13.18B |
| 10 | DGX | Quest Diagnostics Incorporated | 19.12B | 0.95% | 1,025,575 | 10.16B |
| 11 | ILMN | Illumina, Inc. | 12.72B | -0.21% | 1,530,685 | 4.34B |
| 12 | EXAS | Exact Sciences Corporation | 10.74B | 0.83% | 2,052,238 | 2.83B |
| 13 | RVTY | Revvity, Inc. | 10.53B | -1.27% | 1,023,528 | 2.77B |
| 14 | ICLR | ICON Public Limited Company | 10.17B | 0.79% | 879,746 | 8.19B |
| 15 | QGEN | Qiagen N.V. | 9.11B | -0.64% | 1,205,825 | 2.00B |
| 16 | MEDP | Medpace Holdings, Inc. | 8.48B | 0.63% | 265,914 | 2.16B |
| 17 | CRL | Charles River Laboratories International, Inc. | 6.72B | 0.83% | 775,603 | 4.02B |
| 18 | GH | Guardant Health, Inc. | 4.71B | 2.56% | 1,340,074 | 774.00M |
| 19 | RDNT | RadNet, Inc. | 4.25B | -0.28% | 454,155 | 1.87B |
| 20 | SHC | Sotera Health Company | 3.45B | -0.82% | 664,349 | 1.11B |
| 21 | VCYT | Veracyte, Inc. | 2.13B | -0.88% | 612,277 | 463.39M |
| 22 | WGS | GeneDx Holdings Corp. | 2.04B | 6.34% | 657,571 | 330.14M |
| 23 | TWST | Twist Bioscience Corporation | 1.69B | 0.36% | 781,837 | 347.68M |
| 24 | GRAL | GRAIL, Inc. | 1.45B | 3.64% | 779,976 | 130.71M |
| 25 | NEOG | Neogen Corporation | 1.32B | -2.10% | 3,122,589 | 906.00M |
| 26 | OPK | OPKO Health, Inc. | 999.25M | -0.79% | 2,183,581 | 689.41M |
| 27 | NEO | NeoGenomics, Inc. | 953.63M | 1.79% | 1,539,691 | 672.36M |
| 28 | CDNA | CareDx, Inc | 943.79M | -0.88% | 982,166 | 346.42M |
| 29 | FLGT | Fulgent Genetics, Inc. | 618.31M | -1.02% | 213,130 | 292.45M |
| 30 | CSTL | Castle Biosciences, Inc. | 464.84M | 1.32% | 266,906 | 347.08M |
| 31 | PSNL | Personalis, Inc. | 422.19M | 3.46% | 484,344 | 85.69M |
| 32 | MYGN | Myriad Genetics, Inc. | 360.41M | -0.51% | 1,612,910 | 831.30M |
| 33 | XGN | Exagen Inc. | 144.24M | 9.45% | 600,977 | 56.72M |
| 34 | ATLN | Atlantic International Corp. | 136.60M | 9.05% | 39,162 | 444.80M |
| 35 | PRE | Prenetics Global Limited | 134.38M | -8.19% | 63,229 | 30.62M |
| 36 | MDXH | MDxHealth SA | 100.97M | -0.97% | 60,462 | 94.51M |
| 37 | OCX | OncoCyte Corporation | 96.38M | -2.62% | 17,123 | 3.84M |
| 38 | FONR | FONAR Corporation | 89.46M | 0.29% | 109,275 | 103.02M |
| 39 | NOTV | Inotiv, Inc. | 72.83M | 0.47% | 203,327 | 480.40M |
| 40 | BDSX | Biodesix, Inc. | 50.01M | -3.74% | 3,823,727 | 74.46M |
| 41 | BNR | Burning Rock Biotech Limited | 34.99M | 0.62% | 21,939 | 70.67M |
| 42 | PRPO | Precipio, Inc. | 14.55M | -2.15% | 10,050 | 20.03M |
| 43 | PRPH | ProPhase Labs, Inc. | 13.31M | 4.36% | 878,071 | 5.85M |
| 44 | MYNZ | Mainz Biomed N.V. | 7.17M | - | 46,850 | 893.99K |
| 45 | STRR | Star Equity Holdings, Inc. | 6.42M | -2.89% | 30,980 | 57.17M |
| 46 | CHEK | Check-Cap Ltd. | 4.96M | -0.53% | 7,217 | - |
| 47 | BIAF | bioAffinity Technologies, Inc. | 4.78M | -4.87% | 1,572,808 | 8.81M |
| 48 | XWEL | XWELL, Inc. | 4.73M | -2.17% | 8,910 | 32.19M |
| 49 | APDN | Applied DNA Sciences, Inc. | 3.54M | -1.02% | 1,006,908 | 3.79M |
| 50 | ISPC | iSpecimen Inc. | 2.67M | -6.14% | 38,000 | 8.06M |
| 51 | NDRA | ENDRA Life Sciences Inc. | 2.30M | -0.64% | 15,386 | - |